The synthesis and spectroscopic characterization of discrete, water soluble, imidazolate-bridged copper(I1) complexes are reported. Binuclear imidazolate-bridged complexes were crystallized from basic aqueous or methanolic solutions of Cu(pip)2+, pip = 24 (2-(2-pyridyl)ethylimino)methyl]pyridine, or CU(PMDT)~+, PMDT = 1,1,4,7,7-pentamethyldiethylenetriamine, and various substituted imidazoles. The condensation of imidazole-4,5-dicarboxaldehyde with (2-(2-aminoethyl)-pyridine)copper(II) afforded the Cu2bpim3+ cation, where bpim is 4,5-bis[(2-(2-pyridyl)ethylimino)methyl]imidazolate. Addition of imidazole and sodium hydroxide to aqueous solutions of this cation yielded the tetranuclear complex [C~~bpim(im)]~(N0~)~4H~O (im = imidazolate). Potentiometric titrations and solution electron spin resonance spectroscopic studies showed that the integrity of the imidazolate bridge in the Cu2bpim3+ cation is maintained in the range 3.5 < pH < 11.5. Similar studies of the [Cu(pip)12im3+ complex revealed that the bridge is broken both by protonation of the imidazolate group at low pH and by competition with hydroxide ions at high pH. Four protons are reversibly titrated in solutions of [Cu2bpim(im)]:+ corresponding to protonation of the imidazolate rings that link the two Cu2bpim3+ units in this complex to form 2 equiv of imidazolium ion.
IntroductionThe imidazolate (im) anion, the deprotonated form of im-
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.